Lexapro News and Research

RSS
First reliable method to predict whether SSRIs work on depressed patients

First reliable method to predict whether SSRIs work on depressed patients

Forest Laboratories second quarter net sales increase 9.0% to $1,130.3 million

Forest Laboratories second quarter net sales increase 9.0% to $1,130.3 million

Common painkillers decrease effectiveness of antidepressants: Study

Common painkillers decrease effectiveness of antidepressants: Study

Forest Labs fourth quarter net sales increase 9.7% to $1,091.9 million

Forest Labs fourth quarter net sales increase 9.7% to $1,091.9 million

Forest Labs enters definitive merger agreement to acquire Clinical Data

Forest Labs enters definitive merger agreement to acquire Clinical Data

Mouse model could help develop new classes of antidepressant drugs

Mouse model could help develop new classes of antidepressant drugs

Forest Laboratories third quarter net sales increase 6.7% to $1,063.9 million

Forest Laboratories third quarter net sales increase 6.7% to $1,063.9 million

Shire announces results of Vyvanse Phase 2 signal finding study for Major Depressive Disorder

Shire announces results of Vyvanse Phase 2 signal finding study for Major Depressive Disorder

Forest Laboratories second quarter net sales increase 7.7% to $1,037.3 million

Forest Laboratories second quarter net sales increase 7.7% to $1,037.3 million

Forest Laboratories reports first-quarter diluted EPS of $0.39

Forest Laboratories reports first-quarter diluted EPS of $0.39

Combination therapy for severe depression

Combination therapy for severe depression

Sermo Category Report: About 30% of patients suffer from depression

Sermo Category Report: About 30% of patients suffer from depression

Forest Laboratories' fourth-quarter net sales up 11.0% to $995.6M

Forest Laboratories' fourth-quarter net sales up 11.0% to $995.6M

Treatment options available for GAD

Treatment options available for GAD

Medco Health Solutions launches Medco TRC for oncology patients

Medco Health Solutions launches Medco TRC for oncology patients

FREEDRUGCARD.US launches new Rx savings program to reduce prescription drug prices

FREEDRUGCARD.US launches new Rx savings program to reduce prescription drug prices

Bipolar disorder drug market to decline from $6.3 billion to $5 billion

Bipolar disorder drug market to decline from $6.3 billion to $5 billion

Caraco closes Asset Purchase Agreement with Forest as part of ANDA patent litigation settlement

Caraco closes Asset Purchase Agreement with Forest as part of ANDA patent litigation settlement

Mayo Clinic scientists conduct clinical study on functional dyspesia patients

Mayo Clinic scientists conduct clinical study on functional dyspesia patients